Gland Pharma has secured USFDA approval for Angiotensin II Acetate injection, 2.5 mg/mL, indicated for treating blood pressure in adults with septic or other distributive shock. This significant milestone allows the company to expand its product portfolio and cater to the critical healthcare needs of patients with hypertension complications. Read more from indiainfoline.com